| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/07/2008 | US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080032335 Provides polypeptide having wide substrate specificity and having omega 3 fatty acid desaturation activity, which makes efficiently unsaturated bond at omega 3 position, and a polynucleotide coding for the same; by expressing the polypeptide in the organism, mass production of n-3 series PUFAs is enabled |
| 02/07/2008 | US20080032334 increase the production of monocytic cells or moncyte cell progenitors by culturing bone marrow or blood cells with a polypeptide for use in treatment and prevention of viral hepatitis diseases; N-terminal methionine; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus, leukemia |
| 02/07/2008 | US20080032333 Polynucleotides encoding soluble zalpha11 cytokine receptors |
| 02/07/2008 | US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders |
| 02/07/2008 | US20080032331 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 02/07/2008 | US20080032330 Process for self-assembly of structures in a liquid |
| 02/07/2008 | US20080032329 Cell-free protein synthesis method with the use of linear template DNA and cell extract therefor |
| 02/07/2008 | US20080032323 Nucleic Acid Construct Containing a Nucleic Acid Derived From the Genome of Hepatitis C Virus (Hcv) of Genotype 2A, and a Cell Having Such Nucleic Acid Construct Introduced Therein |
| 02/07/2008 | US20080032300 Lupac Bifunctional Marker and Its Use in Protein Production |
| 02/07/2008 | US20080032296 Sequences with FabA-like beta -hydroxyacyl-ACP dehydrase (DH) activity; biosynthesis of polyunsaturated fatty acids (PUFAs) |
| 02/07/2008 | US20080032289 Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor |
| 02/07/2008 | US20080031895 Influenza virus-like particle (VLP) compositions |
| 02/07/2008 | US20080031873 Humanized monoclonal antibody 31.1 as an anticancer agent |
| 02/07/2008 | US20080031863 Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease |
| 02/07/2008 | US20080031853 treating Hepatitis-C virus; covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides |
| 02/07/2008 | CA2658800A1 Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and nonfucosylated forms |
| 02/07/2008 | CA2658301A1 A method of producing recombinant biological products |
| 02/07/2008 | CA2555137A1 Puroindolines as fusion-protein carriers in molecular pharming |
| 02/06/2008 | EP1884568A1 Method for identification of compound having antidepressant effect |
| 02/06/2008 | EP1883705A2 Multiplex method for increased proteomic coverage from histopathologically processed biological samples using liquid tissue preparations |
| 02/06/2008 | EP1883650A2 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c |
| 02/06/2008 | EP1402036B1 Expression vectors encoding bacteriophage signal peptides |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | EP1021728B1 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
| 02/06/2008 | EP0678524B1 Anti-human soluble fibrin antibodies, hybridoma producing them, and immunoassaying method |
| 02/06/2008 | CN101120092A Co-expression of multiple protein chains or subunits |
| 02/06/2008 | CN101120085A Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate |
| 02/06/2008 | CN101120019A Antibody specifically reacting with ages derived from 3,4-dge |
| 02/06/2008 | CN101120012A Metabolites of cyclosporin analogs |
| 02/06/2008 | CN101119745A Lectin compositions and methods for modulating an immune response to an antigen |
| 02/06/2008 | CN101117642A Polypeptide capable of lowering blood pressure and method for preparing same |
| 02/06/2008 | CN101116744A Combination neisserial compositions |
| 02/06/2008 | CN100366750C Process for producing target substance through fermentation |
| 02/06/2008 | CN100366735C Sebocytes, sebocyte cell lines and applications thereof |
| 02/06/2008 | CN100366632C Method for extracting protein from paraffin-embedded tissue |
| 02/06/2008 | CN100366631C IgG Fc/HIV-gp120/C3d fusion protein |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |
| 02/06/2008 | CN100366290C Coccidial vaccine and methods of making and using same |
| 02/05/2008 | US7326782 Nucleotide sequences coding functional fragment of viomycin gene cluster for use in treatment of tuberculosis |
| 02/05/2008 | US7326773 PRO6493 antibodies |
| 02/05/2008 | US7326770 H. pylori fucosyltransferases |
| 02/05/2008 | US7326767 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 02/05/2008 | US7326689 Pseudomycins useful against plant diseases |
| 02/05/2008 | US7326682 Conotoxin peptides |
| 02/05/2008 | US7326681 Methods for producing modified glycoproteins |
| 02/05/2008 | US7326569 Hybridoma cell lines producing chimeric antibody having the variable regions of the antibody produced by a cell line with ATCC (TM) deposit number HB11364, HB11637, or HB11363 |
| 02/05/2008 | US7326566 Compositions and methods for screening antimicrobials |
| 02/05/2008 | US7326553 Maltose-1-phosphate-producing enzyme |
| 02/05/2008 | US7326551 Nucleotide sequences coding polypeptide for use in generation of bacteria which generate synthetic fuels |
| 02/05/2008 | US7326549 Myo-inositol oxygenases |
| 02/05/2008 | US7326548 starch conversion for producing fermentation products, such as ethanol, and syrups, such as glucose; fusion polypeptide; mixture with alpha-amylase |
| 02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2008 | US7326543 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7326531 Proteases from gram-positive organisms |
| 02/05/2008 | US7326419 Membrane proteins or polypeptides, used as vaccines or for medical diagnosis |
| 02/05/2008 | US7326413 Antibodies against the PRO1434 polypeptide |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | CA2283597C Reduced cortisol conjugates |
| 02/05/2008 | CA2225963C Transforming growth factor beta crystals |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 02/01/2008 | WO2007012188A1 GLP/1/EXENDM 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 02/01/2008 | CA2658673A1 Composition and method for prevention and treatment of type i and type ii diabetes |
| 01/31/2008 | WO2008014054A2 Bmp-7 variant compositions, methods and uses |
| 01/31/2008 | WO2008013943A2 High-cell density fed-batch fermentation process for producing recombinant protein |
| 01/31/2008 | WO2008013552A2 Fully human hybridoma fusion partner cell lines |
| 01/31/2008 | WO2008013257A1 Monoclonal antibody to soluble lox-1 |
| 01/31/2008 | WO2008013242A1 Method for production of n36-binding peptide |
| 01/31/2008 | WO2008013067A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 01/31/2008 | WO2008011711A1 Cancerous disease modifying antibodies |
| 01/31/2008 | WO2007136856A3 Heyl as a therapeutic target and a diagnostic marker for neoplasia and uses therefor |
| 01/31/2008 | WO2006113909A3 Humanized anti-cd70 binding agents and uses thereof |
| 01/31/2008 | WO2005118646A3 Epitope directed selection of antibodies to murine tissue factor |
| 01/31/2008 | WO2004067722A3 Facls as modifiers of the rb pathway and methods of use |
| 01/31/2008 | US20080027148 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080027020 Human Neuropeptide Receptor |
| 01/31/2008 | US20080026999 Dehydration, cyclization of peptide; prevention, therapy for bacteria infections; amino acid sequences |
| 01/31/2008 | US20080026995 Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 01/31/2008 | US20080026989 Human Ependymin |
| 01/31/2008 | US20080026976 Highly productive alpha-amylases |
| 01/31/2008 | US20080026948 Protein (poly)peptides libraries |
| 01/31/2008 | US20080026440 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 01/31/2008 | US20080026439 Pufa polyketide synthase systems and uses thereof |
| 01/31/2008 | US20080026438 Pufa polyketide synthase systems and uses thereof |
| 01/31/2008 | US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF |
| 01/31/2008 | US20080026426 Anti-infective therapy |
| 01/31/2008 | US20080026425 High-Cell Density Fed-Batch Fermentation Process for Producing Recombinant Protein |
| 01/31/2008 | US20080026423 DEP-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 01/31/2008 | US20080026422 Adding an desired amino acid analog to a medium containing a host cell with a vector coding for aminoacyl-tRNA synthetase and a vector coding for the polypeptide of interest; and growing the cell to produce the modified polypeptide |
| 01/31/2008 | US20080026421 Transgenic cells comprising peroxisomal membrane polypeptide (PMP) for transport of intracellular proteins to ouside of cell |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080026363 Acetyl coa carboxylase 2 sequences and methods |
| 01/31/2008 | US20080026072 glycoproteins having alpha 1,4-linked N-acetylglucosamine residue from milk of mammal containing carrier polypeptide with alpha 1,4-N-acetylglucosaminyl transferase; for treatment or prevention of gastric ulcers |
| 01/31/2008 | US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
| 01/31/2008 | US20080026000 Nicotine hapten where nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization; preventing nicotine addiction |
| 01/31/2008 | US20080025999 Yersinia species compositions |
| 01/31/2008 | US20080025988 Monoclonal Antibody And Use Thereof |